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Background: In the COVID-19 pandemic, older adults from vulnerable ethnoracial groups are at high risk
of infection, hospitalization, and death. We aimed to explore the pandemic’s impact on the well-being
and cognition of older adults living in the United States (US), Argentina, Chile, Mexico, and Peru.
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Findings: Mean age for all participants was 66.7 (SD = 7.7) years and mean education was 15.4 (SD = 2.7)
years. Compared to Whites, Latinos living in the US reported greater economic impact (p < .001,

Methods: 1,608 (646 White, 852 Latino, 77 Black, 33 Asian; 72% female) individuals from the US and
four Latin American countries aged ≥ 55 years completed an online survey regarding well-being and
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treatment [10,11]. For Latinos and Blacks, a greater multifactorial
risk of COVID-19 encompasses long-standing systemic structures
that restrict access to a complex healthcare system needed to create, sustain, and protect life beyond biological processes [12,13].
Greater perceived loneliness, lower life purpose, higher memory
concerns, and greater discrimination are associated with poorer
health outcomes and higher mortality among older adults [1417]. Moreover, loneliness, and depression are related to subjective
experiences like social isolation or perceived stress [18]. Ethnicity and culture can inﬂuence the development of these symptoms
among elderly populations [19]. Preventative measures and national mandates emphasizing shelter-in-place/stay-at-home likely
exacerbate stress, isolation, and discrimination for vulnerable populations [20]. The pandemic’s impact extends to low- and middleincome countries (LMICs) with differential effects resulting from
access to screening/testing, policies mandating work, school, travel,
and reporting of COVID-19 cases and deaths. LMICs encounter challenges with more fragile supply chains, collectivistic-based households promoting higher transmission, and less developed sanitation systems [21,22].
There are limited data on the impact of COVID-19 on ethnoracial groups and whether those in LMICs face greater challenges
than those in the US [23]. This study presents baseline data from
an ongoing international effort entitled, “The Impact of COVID-19
on Well-being and Cognition in Older Ethnically Diverse Individuals,” launched in May, 2020. This study investigates if differences
exist in cognitive concerns, loneliness, life purpose, perceived discrimination, and pandemic impact among older adults across ethnoracial groups living in the US, and in Latin American countries.
We hypothesize that 1) Latinos and Blacks living in the US will be
more impacted by the pandemic compared to non-Latino Whites
and 2) that older individuals living in Argentina, Chile, Mexico, and
Peru will encounter more burden compared to their Latino counterparts living in the US.

Research in context

Evidence before this study
A PubMed search from January 1 to October 21, 2020, using the terms “(COVID-19 OR SARS-CoV2) AND (ethnoracial
OR race OR ethnicity) AND (older OR elderly adult) AND (discrimination OR loneliness OR life purpose OR subjective cognitive concerns) AND (LMICs OR low income country OR middle income country OR Latin America)”. Only a handful of
studies retrieved appeared relevant and discussed the importance of social distancing, resources in LMICs, and data limitations in addressing inequities in the pandemic. We were
unable to ﬁnd a single study that examined the impact of the
pandemic and psychosocial outcomes in ethnoracial groups
in Latin America and the US.
Added value of this study
In the US, Latinos indicated more economic challenges,
while Black older adults reported more perceived discrimination than other groups in the US. Latinos living in Chile,
Mexico, and Peru experienced higher pandemic impact than
those in the US. In contrast, those in Argentina, Chile, and
Peru experienced lower perceived discrimination than Latinos
residing in the US. These ﬁndings provide evidence that the
pandemic burden is different for non-White individuals and
those in low-and-middle-income countries.
Implications of all the available evidence
Discrimination, loneliness, life purpose, and memory concerns deeply inﬂuence an individual’s health and interact
with social determinants of health. Ethnoracial groups and
older adults are at a higher risk for health disparities, and
COVID-19 exponentially increases mortality and morbidity
risks. Future studies should examine between-country differences and also how mediators like income and coping skills
modify the pandemic’s impact.

2. Methods
1. Introduction

2.1. Design and sampling

The spread of Coronavirus Disease 2019 (COVID-19), caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
was declared a pandemic on March 11, 2020, by the World Health
Organization [1]. To date, the worldwide impact grosses over 124
million cases, with over 2.74 million deaths [2]. Many countries
continue to report higher cases and related deaths. The Centers for
Disease Control and Prevention (CDC) reported over 29.9 million
cases and over 544,0 0 0 deaths in the US, resulting from the pandemic (1/21/20–3/24/2021) [3]. Risk is increased through physical
contact, enclosed environments, and longer exposure duration [4].
Sociobiological risk factors, older age, and pulmonary and cardiovascular comorbidities increase the risk of poor outcomes [5,6]. In
the United States (US), healthcare disparities are exacerbated for
ethnic and racial (ethnoracial) groups [7]. Compared to non-Latino
Whites, the CDC reports higher rate ratios of cases (2.8, 2.6), hospitalizations (4.6, 4.7), and deaths (1.1, 2.1) among Latino and Black
individuals, respectively [8]. A higher number of Latinos and Blacks
have several of the aforementioned risk factors, increasing the risk
for a more severe course if infected [9].
Long-term recovery is complicated by comorbidities, psychological sequelae, and lingering symptoms/deconditioning post-

We report cross-sectional ﬁndings from an ongoing, longitudinal study of the general noninstitutionalized older adult population (55 years or older). The sample is non-probabilistic and was
selected based on convenience in the US and several Latin American Spanish-speaking countries (Argentina, Chile, Mexico, Peru).

∗
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2.2. Procedure
A group of researchers from the US and 14 Latin American
countries formed in May 2020. The survey was launched simultaneously in the US and Latin America. The ﬁrst survey was completed on May 15th, 2020, and the last survey data included in
this study was completed on September 9th, 2020. Participants
were recruited via social media outlets (e.g., Twitter, Facebook), researcher’s contacts (family, friends, ongoing studies), virtual meetings, and word-of-mouth. All participants completed a one-hour
survey (online with a computer or smartphone or via phone call
with a researcher) in English (n = 844) or Spanish (n = 852).
Study data were collected, accessed (VLT & YTQ), and managed
in REDCap (Research Electronic Data Capture) [24] hosted at Massachusetts General Hospital. All measures were forward-and-back
translated to Spanish following World Health Organization guidelines [25].

Corresponding author.
E-mail address: yquiroz@mgh.harvard.edu (Y.T. Quiroz).
Indicates shared authorship.
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2.3. Ethical considerations

ates. Parallel GLM models were repeated comparing each individual country (Argentina, Chile, Mexico, and Peru) to Latinos residing
in the US. Mean substitution was used for the corresponding ethnoracial group for eight participants with missing educational data.
Analyses were conducted in SPSS version 27 (Chicago, IL, USA).

The study was approved by the Massachusetts General Brigham
Human Research Review Board, and Local Institutional Review
Boards from Puerto Rico (Ponce Medical School Foundation, Ponce
Research Institute), Perú (Universidad Católica San Pablo, Comité
de Ética de la Dirección de Investigación), México (Instituto Nacional de Ciencias y Nutrición Salvador Zubirán, Comité de Ética
en Investigación), Chile (Universidad de Chile, Comité de Ética
de Investigación en Seres Humanos), Ecuador (Neuromedicenter:
Unidad de Trastornos Cognitivos – Centro Diurno), Republica Dominicana (Universidad Nacional Pedro Henriquez Ureña), and Argentina (Fundación Favaloro Hospital Universitario, Comité de Ética
en Investigación). All participants provided online consent.

2.6. Role of the funding source
The funding source(s) had no involvement in the study design,
data collection, analysis, or interpretation.
3. Results
3.1. Participants

2.4. Outcome variables/questionnaires

The initial sample included 1845 participants. The following
were excluded: thirteen participants who reported living outside
of the United States or Latin America; nine participants who reported being born outside of the United States or Latin America;
eight participants who were statistical outliers; thirty-four participants who did not report their ethnicity/cultural background; and
26 participants who reported ‘Other’ ethnicities. Due to low participation among Native American (n = 6) and Native Hawaiian or
Paciﬁc Islander (n = 2) participants, these individuals were also
removed from the analyses. Similarly, due to a lower number of
survey responses (<50), 139 participants were removed across 10
Latin American countries (Fig. 1). The ﬁnal sample (N = 1608) included: 646 non-Latino White, 717 Latino, 77 Black, and 33 Asian
individuals. The sample included 135 (15.8%) Latinos living in the
US and 717 living in the four Latin American countries; Argentina
(n = 106), Chile (n = 151), Mexico (n = 308), and Peru (n = 152).
The mean age of the total sample was 66.74 years (range 55–
95), 15.4 mean years of education (range 0–26), and an average of
72.3% females (range 67–87%) across the groups (Tables 1 and 2).
In the Black group, there was a slightly higher percentage (84%) of
females compared to males. Within the US sample, 64 (7.2%) participants reported having experienced COVID-19 symptoms, six reported having been tested and currently having the disease, and 11
reported having tested positive for the disease but no longer being
symptomatic. Within Argentina, Chile, Mexico, and Peru, 10 (1.4%)
reported having experienced COVID-19 symptoms, 5 reported having been tested and currently having the disease, and 20 reported
having tested positive for the disease (Table 2). The US sample had
59.4% married/in a civil union with similar proportions across ethnoracial groups, but a higher proportion of single individuals in the
Black sample, χ 2 (3, [n = 889], p = .028. Self-reported household
income (low/middle and high) did not differ between the ethnoracial groups. There were no differences between older individuals residing in Argentina, Chile, Mexico, or Peru, when compared
to those living in the US on marital status or household income
(Table 2).

Participants completed a sociodemographic questionnaire, selfreport measures, and indicated the country of residence. Ethnoracial group was assessed with two US Census questions about selfidentiﬁed race (e.g., White, Black, Asian) and ethnicity (Latino versus Non-Latino). Use of White, Black, and Asian entail non-Hispanic
origin. For US comparisons, Latinos were grouped irrespective of
their race, whereas non-Latino individuals were separated by race.
The Epidemic-Pandemic Impacts Inventory (EPII) [26] was used
to measure overall impact. This is a newly developed questionnaire for assessing the coronavirus pandemic’s impact on personal
and family life including employment, education, home life, social activities, economic, emotional health and well-being, physical
health, physical distancing and quarantine, infection history, and
positive change. Greater subscale and total scores suggest more
burden, except for the positive change subscale, in which higher
scores suggest less burden (See Appendix A).
The Everyday Discrimination Scale [27] (Short Version)
[28] asks about experiences of unfair treatment in day-to-day
life. Higher scores indicate greater perceived discrimination. The
Everyday Cognition (ECog) Scale [29] is a subjective measure
of current cognitive daily abilities compared with past abilities
(ten years earlier). The 7-Memory questionnaire measures subjective memory concerns (SMC) [30,31]. Higher scores indicate
greater memory concerns. The De Jong Gierveld Loneliness Scale
[32] measures overall emotional and social loneliness across sixitems. Higher scores indicate greater loneliness. The Life Purpose
Questionnaire [33] is a modiﬁed 10-item measure of Psychological
Well-Being [34]. Higher scores indicate greater purpose in life.
2.5. Statistical analyses
Descriptive statistics using student’s t-test and Chi-square examined group differences in demographic variables. In the US sample, one-way univariate general linear models (GLM) compared
four ethnoracial groups across six outcome measures. Additionally, ten one-way GLM compared the groups in the ten EPII subscales. Age (years, continuous), education (years, continuous), and
sex (male/female, dichotomous) were included as covariates in all
analyses. The ten models using EPII as the outcome were adjusted
for multiple comparisons using Bonferroni correction (α = 0.005
[0.05/10) [35]. Additional one-way GLM analyses were used to
compare each Latin American country and the US Latinos in the
EPII subscales and the ﬁve outcome measures. For each set of analyses, the Bonferroni correction described above was included to
correct for multiple comparisons in the EPII subscales.
Pearson correlations examined the relationship between the
EPII total and the ﬁve outcome measures. Finally, three one-way
GLM compared the groups in the EPII total, including the Loneliness scale, Life Purpose Questionnaire, and ECog Total as covari-

3.2. Ethnoracial differences in the US
In the US, the ethnoracial groups differed in age, where the
White group was older than the Latino group (p < 0.001). Years
of education differed between the groups (p < 0.001), speciﬁcally
between Whites and Latinos (p = .012), and Asians and Latinos
(p = .001). Whites and Asians reported higher education than Latinos. Latinos reported higher economic impact suggesting more ﬁnancial hardships on the EPII compared to Whites (p < .001) and
Blacks (p = .01). The Black and Latino participants reported more
positive change on the EPII than White participants (all p < .001),
suggesting more positive reframing and coping with the pandemic.
On the self-report of everyday perceived discrimination, Blacks
experienced everyday discrimination more often than the other
3
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Fig. 1. Study ﬂowchart of participants.

groups, (all p < .001). There were no between-group differences on
the EPII total or its subscales, the 7-Memory Questionnaire, Loneliness Scale, Life Purpose Questionnaire, or ECog Total (Table 3).
The EPII total signiﬁcantly correlated (all p < .001—low magnitude) with the Loneliness scale (r = 0.35), Life Purpose Questionnaire (r = −0.20), ECog Total (r = 0.23), Discrimination scale
(r = 0.37), and 7-Memory Questionnaire (r = 0.29) [Fig. 2].
The inclusion of the Loneliness scale, Life Purpose Questionnaire, and ECog Total into the models examining the EPII were signiﬁcant as main effects (all p < .001) and improved the models,
as indicated by an increased adjusted R2 value from 0.060 in the
original model to 0.186, 0.108, and 0.119, respectively. A signiﬁcant
interaction (p = .014) between the ethnoracial groups and the ECog
suggested that the Black participants who reported more cognitive
concerns also reported greater pandemic impacts than the other
groups Fig. 3.

can countries and Latinos living in the US (See Table 4). Argentinians reported greater pandemic effects on the Education and
Training subscale (p = .001), compared to the US Latinos. Chileans
also reported greater detrimental effects in Education and Training (p < .001) and less discrimination than US Latinos (p = .006).
Mexicans had a higher EPII total score, indicating greater overall
pandemic effects (p < .001), including the Education and Training
(p < .001), Home Life (p = .002), and Economic effect (p < .001)
subscales. Conversely, Mexicans reported experiencing greater Positive Change (p = .001) and more subjective memory concerns
(p = .010) than US Latinos. Peruvians had higher EPII total scores
(p < .001), as well as higher scores in the Economic (p < .001),
Physical Distancing (p < .001), Infection History (p < .001), and
positive change (p = .001) subscales.
Among Latinos living in the US, 112 (83%) reported having lived
in the country for over 20 years, eight reported living 15–20 years,
and the rest lived for less than 15 years. There were no differences
in age for Latinos living in the US with those residing in Chile,
Mexico, or Peru; however, those living in Argentina were slightly
older (p < .001). There were no differences in levels of education.
Within the US Latinos, scores on the EPII total signiﬁcantly correlated with the Loneliness scale (r = 0.32, p = .001) and Dis-

3.3. Between country comparisons
A total of 717 individuals reported living in 4 Latin American countries (Argentina: 106, Chile: 151, Mexico: 308, Peru: 152)
and 135 Latinos reported living in the US. Outcome measures
were compared among respondents from the four Latin Ameri4
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Fig. 2. Associations Between Total EPII and Outcome Measures in the US participants.
EPII = Epidemic-Pandemic Impacts Inventory; ECog = Everyday Cognition Scale. A) Correlation between De Jong Gierveld Loneliness Scale and Total EPII; B) Correlation between Life Purpose Questionnaire and Total EPII; C) Correlation between Total ECog and Total EPII; D) Correlation Between Discrimination Scale and Total EPII; E) Correlation
between 7-Memory Questionnaire and Total EPII.

crimination scale (r = 0.32, p < .001). Within the Argentinian participants, scores on the EPII total signiﬁcantly correlated with the
Loneliness scale (r = 0.21, p = .028), Discrimination scale (r = 0.27,
p = .006), and 7-Memory Questionnaire (r = 0.24, p = .015).
Within the Latinos in Chile, scores on the EPII total signiﬁcantly
correlated (all p < .001—low magnitude) with the Loneliness scale

(r = 0.48), ECog Total (r = 0.21, p = .010), Discrimination scale
(r = 0.43), and 7-Memory Questionnaire (r = 0.35). Within the
Mexican participants, scores on the EPII total signiﬁcantly correlated (all p < .001—low magnitude) with the Loneliness scale
(r = 0.41), Life Purpose Questionnaire (r = −0.15; p = .007), ECog
Total (r = 0.28), Discrimination scale (r = 0.33), and 7-Memory

Table 3
Mean differences in outcome measures in the US between ethnoracial groups.
United States Sample
Ethnoracial Group

EPII Work and Employment
EPII Education and Training
EPII Home Life
EPII Social Activities
EPII Economic
EPII Emotional Health and Well-Being
EPII Physical Health Problems
EPII Physical Distancing and Quarantine
EPII Infection History
EPII Positive Change
EPII Total
7-Memory Questionnaire
De Jong Gierveld Loneliness Scale
Life Purpose Questionnaire
Discrimination Scale
ECog Total

Non-Latino White
M (SE)

Latino
M (SE)

Black
M (SE)

Asian
M (SE)

p

ηp 2

0.84 (0.06)
0.07 (0.01)
0.45 (0.04)
5.05 (0.09)
0.20 (0.03)
1.91 (0.06)
2.54 (0.07)
1.47 (0.06)
0.16 (0.02)
6.02 (0.15)
12.69 (0.24)
1.59 (0.08)
2.87 (0.08)
37.30 (0.32)
8.41 (0.17)
8.92 (0.14)

0.82 (0.11)
0.12 (0.03)
0.42 (0.08)
5.18 (0.18)
0.49 (0.05)
1.99 (0.12)
2.65 (0.14)
1.62 (0.12)
0.25 (0.04)
7.46 (0.31)
13.54 (0.49)
1.66 (0.17)
2.76 (0.17)
37.93 (0.66)
8.94 (0.35)
8.46 (0.28)

0.66 (0.15)
0.12 (0.03)
0.74 (0.11)
5.48 (0.24)
0.24 (0.07)
1.73 (0.16)
2.54 (0.18)
1.27 (0.16)
0.23 (0.06)
8.07 (0.42)
12.99 (0.65)
1.44 (0.22)
2.34 (0.21)
39.39 (0.87)
11.62 (0.47)
8.08 (0.36)

0.79 (0.22)
0.06 (0.05)
0.23 (0.16)
4.67 (0.35)
0.29 (0.10)
1.46 (0.23)
2.37 (0.27)
1.37 (0.23)
0.12 (0.09)
6.35 (0.61)
11.34 (0.95)
1.76 (0.33)
2.81 (0.31)
37.48 (1.28)
8.10 (0.69)
8.19 (0.53)

0.69
0.26
0.03
0.18
< 0.001†
0.14
0.79
0.30
0.17
< 0.001†
0.17
0.82
0.11
0.12
< 0.001∗
0.05

.002
.005
.010
.005
.031
.006
.001
.004
.006
.040
.006
.001
.007
.007
.050
.009

Abbreviations: M = Mean; SE = Standard Error; EPII = Epidemic-Pandemic Impacts Inventory; ECog = Everyday Cognition Scale.
†
p < .005 (Adjusted for Bonferroni correction).
∗
p < .05.
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Table 1
Demographic Characteristics of the US Participants.
United States Sample
Non-Latino White

Age
Education
Sex Male
Female
Marital
Single
Not Single
Status
Income
Low/Medium
High
COVID-19 Symptoms
Positive test and current symptoms
Positive test no current symptoms

Latino

Black

Asian

M

SD

n

M

SD

n

M

SD

n

M

SD

n

p

67.72
15.93

7.67
2.06

645
645
171
474
250 (38.8%)
394 (61.2%)
525 (82.9%)
108 (17.1%)
48 (5.5%)
2 (0.2%)
7 (0.8%)

64.53
15.28

7.30
2.99

135
135
27
107
57 (42.2%)
78 (57.8%)
118 (89.4%)
14 (10.6%)
9 (1.0%)
4 (0.4%)
4 (0.4%)

66.40
16.09

6.95
1.91

77
77
10
65
43 (55.8%)
34 (44.2%)
67 (87.0%)
10 (13.0%)
6 (0.7%)
0 (0.0%)
0 (0.0%)

66.27
16.91

8.37
1.23

33
33
11
22
11 (33.3%)
22 (66.7%)
25 (75.8%)
8 (24.2%)
1 (0.1%)
0 (0.0%)
0 (0.0%)

< 0.001
< 0.001

Abbreviations: M = Mean; SD = Standard Deviation.
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Table 2
Demographic Characteristics of the Latino Participants by Country.
Latino Sample
Country
Argentina
M

SD

n (%)

Mexico

Peru

USA

SD

n (%)

M

SD

n (%)

M

SD

n (%)

M

SD

n (%)

p

66.10
16.33

7.35
1.54

151

65.42
14.97

7.99
3.03

308

66.41
12.65

7.72
3.99

152

64.53
15.28

7.30
2.99

135

<0.001
<0.001

59 (39.07%)
92 (60.93%)
60 (39.74%)
91 (60.26%)
121 (80.13%)
30 (19.87%)
148 (98.01%)
3 (1.99%)
149 (98.68%)
2 (1.32%)
148 (98.01%)
3 (1.99%)

75 (24.35%)
233 (75.65%)
158 (51.30%)
150 (48.70%)
300 (97.40%)
4 (1.30%)
304 (98.70%)
4 (1.30%)
306 (99.35%)
2 (0.65%)
300 (97.40%)
8 (2.60%)

57 (37.50%)
95 (62.50%)
49 (32.24%)
103 (67.76%)
145 (95.39%)
7 (4.61%)
149 (98.03%)
3 (1.97%)
151 (99.34%)
1 (0.66%)
143 (94.08%)
9 (5.92%)

27 (20%)
107 (79.26%)
57 (42.22%)
78 (57.78%)
118 (87.41%)
14 (10.37%)
135 (100%)
0
131 (97.04%)
4 (2.96%)
131 (97.04%)
4 (2.96%)
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Age
69.36
6.69
106
Education
14.97
2.27
Sex Male
34 (32.08%)
Female
72 (67.92%)
Marital
Single
38 (35.85%)
Status
Not Single
68 (64.15%)
Income
Low/Middle
91 (85.85%)
High
13 (12.26%)
COVIDNo
106 (100%)
19 Yes
0
Symptoms
Positive
No
106 (100%)
test,Yes
0
106 (100%)
cur-No
Positive
test,Yes
0
rent
no
symptoms
Abbreviations:
M = Mean; SD = Standard Deviation.
current
symptoms

Chile
M

EPII Work and Employment
EPII Education and Training
EPII Home Life
EPII Social Activities
EPII Economic
EPII Emotional Health and Well-Being
EPII Physical Health Problems
EPII Physical Distancing and Quarantine
EPII Infection History
EPII Positive Change
EPII Total
7-Memory Questionnaire
De Jong Gierveld Loneliness Scale
Life Purpose Questionnaire
Discrimination Scale
ECog Total
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Table 4
Mean differences in outcome measures in US Latinos and Latinos in Argentina, Chile, Peru, and Mexico.
US
M (SE)

Argentina
M (SE)

p

ηp 2

US
M (SE)

Chile
M (SE)

p

ηp 2

US
M (SE)

Mexico
M (SE)

p

ηp 2

US
M (SE)

Peru
M (SE)

p

ηp 2

0.93 (.14)
0.09 (.04)
0.46 (.09)
5.29 (.19)
0.55 (.11)
1.97 (.14)
2.71 (.14)
1.75 (.14)
0.28 (.05)
7.70 (.34)
14.02 (.54)
1.65 (.17)
2.67 (.18)
38.01 (.74)
9.06 (.41)
8.61 (.29)

1.20 (.14)
0.30 (.05)
0.52 (.10)
4.84 (.20)
0.91 (.12)
2.23 (.15)
3.02 (.15)
2.01 (.15)
0.07 (.05)
7.53 (.36)
15.09 (.57)
1.05 (.18)
2.18 (.18)
37.22 (.79)
7.29 (.43)
8.03 (.30)

0.15
0.001†
0.70
0.09
0.02
0.19
0.11
0.19
0.002†
0.73
0.16
0.01∗
0.05∗
0.44
0.002∗
0.15

.009
.047
.001
.013
.023
.007
.011
.007
.042
.001
.009
.028
.019
.003
.040
.009

1.01 (.14)
0.14 (.04)
0.45 (.10)
5.37 (.20)
0.50 (.09)
2.09 (.14)
2.75 (.15)
1.65 (.14)
0.31 (.06)
7.92 (.34)
14.26 (.57)
1.67 (.17)
2.79 (.18)
37.83 (.66)
9.43 (.41)
8.64 (.27)

1.40 (.12)
0.34 (.04)
0.62 (.09)
5.10 (.17)
0.63 (.08)
2.26 (.12)
3.17 (.13)
2.09 (.12)
0.28 (.05)
8.53 (.30)
15.88 (.51)
1.59 (.15)
2.71 (.17)
38.44 (.58)
7.96 (.36)
8.06 (.23)

0.03
<0.001†
0.20
0.29
0.29
0.35
0.03
0.02
0.64
0.17
0.03
0.72
0.73
0.48
.006∗
.09

.017
.043
.006
.004
.004
.003
.018
.020
.001
.007
.017
.000
.001
.002
.027
.010

1.07 (.13)
0.11 (.05)
0.51 (.12)
5.26 (.20)
0.51 (.12)
2.06 (.13)
2.71 (.15)
1.70 (.14)
0.29 (.06)
7.90 (.30)
14.22 (.58)
1.74 (.19)
2.71 (.19)
37.74 (.69)
9.24 (.40)
8.58 (.29)

1.38 (.09)
0.45 (.03)
0.92 (.08)
5.14 (.13)
1.40 (.08)
2.43 (.09)
2.93 (.10)
2.00 (.10)
0.40 (.04)
9.06 (.21)
17.04 (.40)
2.28 (.13)
2.66 (.13)
37.56 (.48)
8.77 (.28)
8.94 (.20)

0.03
<0.001†
0.002†
0.56
<0.001†
0.01
0.20
0.06
0.08
0.001†
<0.001†
0.01
0.81
0.82
0.30
0.26

.010
.079
.022
.001
.092
.014
.004
.008
.007
.027
.042
.015
<.0001
<.0001
.002
.003

1.04 (.13)
0.16 (.03)
0.50 (.10)
5.30 (.18)
0.50 (.10)
2.13 (.13)
2.62 (.15)
1.55 (.15)
0.29 (.07)
7.78 (.30)
14.08 (.54)
1.70 (.17)
2.88 (.18)
37.95 (.70)
9.11 (.34)
8.62 (.31)

1.46 (.11)
0.09 (.03)
0.61 (.08)
5.76 (.16)
1.17 (.08)
1.91 (.12)
2.43 (.13)
2.30 (.13)
0.93 (.06)
9.10 (.26)
16.66 (.47)
2.00 (.15)
2.77 (.14)
39.25 (.61)
6.93 (.30)
9.58 (.27)

0.02
0.12
0.38
0.06
<0.001†
0.22
0.33
<0.001†
<0.001†
0.001†
<0.001†
0.19
0.64
0.16
<0.001∗
0.02∗

.021
.009
.003
.013
.095
.005
.003
.049
.146
.037
.045
.006
.001
.007
.077
.020

Abbreviations: M = Mean; SE = Standard Error; EPII = Epidemic-Pandemic Impacts Inventory; ECog = Everyday Cognition Scale.
†
p < .005 (Adjusted for Bonferroni correction)
∗
p < .05
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Fig. 3. Associations between Total EPII and outcome measures in the Latino participants, including those residing in the US and those residing in Mexico, Chile,
Argentina and Peru.
EPII = Epidemic-Pandemic Impacts Inventory; ECog = Everyday Cognition Scale. A)
Correlation between De Jong Gierveld Loneliness Scale and Total EPII; B) Correlation
between Life Purpose Questionnaire and Total EPII; C) Correlation between Total
ECog and Total EPII; D) Correlation Between Discrimination Scale and Total EPII; E)
Correlation between 7-Memory Questionnaire and Total EPII.

Questionnaire (r = 0.30). Finally, within the Peruvian participants,
scores on the EPII total signiﬁcantly correlated with the Discrimination scale (r = 0.28, p = .001) and 7-Memory Questionnaire
(r = 0.17, p = .035).

4. Discussion

This prospective, cross-sectional study found no differences in
the pandemic’s self-reported overall impact among older adults
across four US ethnoracial groups. However, Latinos indicated more
economic challenges, like paying bills/rent/utilities and obtaining
medications. Black older adults self-reported more perceived discrimination compared to other groups, while Latinos residing in
the US reported more perceived discrimination than their Latin
American counterparts across four countries. Additionally, Latinos
living in Latin America (i.e., Argentinian, Chileans) self-reported
experiencing higher pandemic impact, especially within Education
and Training, compared to those in the US. There were no differences in self-reported memory concerns, loneliness, or purpose in
life among any of the older adult cohort groups.
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Data on the pandemic’s social impact within and outside of
the US are limited beyond proximal clinical outcomes, incidence,
and mortality statistics [36]. The current ﬁndings provide evidence
and conﬁrmation of initial anecdotal commentaries [7,9,13] that
the pandemic’s burden is different for non-White groups and those
in LMICs. Discrimination is also a driver in the backdrop of the
pandemic and ongoing discussions about equality, race, and ethnicity. Black older adults self-reported more perceived discrimination than the other groups and US Latinos similarly reported
more discrimination than those residing in Argentina, Chile, and
Peru. While it is unclear if perceived discrimination was greater
or reduced for Black participants pre-pandemic, these results support prior ﬁndings of greater discrimination in Black older adults
than their White counterparts [37]. Discrimination inﬂuences if
and when healthcare services are accessed, how information about
the pandemic is interpreted, and trust in the healthcare system [38.39]. Latinos also reported more economic diﬃculties in
this study. Nationally-representative data show that compared to
Whites, Latino adults aged 18–64 were more likely to have diﬃculty accessing and using health care due to language and economic barriers [40]. A prior history of limited healthcare access
and utilization predicts future underutilization of care to manage
chronic conditions. Latinos residing in Chile, Mexico, and Peru reported a higher impact of the pandemic, including greater difﬁculty with work and employment (Chile, Mexico, Peru), education and training (Argentina, Chile, Mexico), economics (Argentina,
Mexico, and Peru), and physical distancing and quarantine (Chile,
Mexico, Peru [e.g., limited physical closeness with a loved one
and household quarantine]). Therefore, despite a higher number of
cases and deaths in the US, particularly among vulnerable populations, the country’s economic infrastructure and reserves may help
reduce the pandemic’s impact than those of LMICs.
The unremarkable ﬁndings on memory concerns (with the exception of Mexicans), loneliness, and life purpose in the ethnoracial groups within and outside the US are also interesting. Participants indicated being healthy with only a small number of reported COVID-19 cases. Older age is associated with more loneliness, leading to anxiety and depression [41]. However, potential mediators for higher loneliness in older adults include poor
health, higher stress, prior mental health problems, and COVID-19
recovery [20]. One longitudinal study of loneliness among US older
adults found little change between January to April 2020 and less
loneliness than younger adults [42]. Our ﬁndings extend these results by assessing race and ethnicity in the US. Greater life purpose suggests a directional relationship with lower loneliness and,
indirectly, a reduced impact of the pandemic among participants
in this sample. However, this may change with recurring surges of
infection and a prolonged period of no effective treatments or vaccines.
This descriptive, cross-sectional study had several limitations,
which limit the generalizability of the results. It is likely that group
differences in the outcomes explored in this study design were
present pre-pandemic and may have been ampliﬁed by the stress
of the pandemic. For example, it is very likely that group differences in perceived discrimination existed pre-pandemic (via historical and social norms) and persist as reinforced (via institutional and social determinants of health) by these results. Data
were cross-sectional and therefore causality cannot be inferred
since data on the outcome measures pre-pandemic were not available nor would recall be helpful in providing an apposite comparison. Given the crucial restrictions resulting from regional, national, and international mandates for social distancing, traditional
in-person recruitment strategies, and testing could not be deployed
and sampling was not random, which limits external validity. Selection bias may have inﬂuenced the results since most respondents completed the survey on a computer or smartphone/tablet

and may differ from individuals who may not have access to such
technology. Evidence of this bias is that the sample was relatively
well-educated (15 years of education on average), indicating postsecondary education (college, trade, vocational schools). This is not
representative of the average/mean years of education statistic in
the United States or in Argentina, Chile, Mexico, and Peru. Particularly, given the high level of education of our respondents from
Latin American countries, our results should be interpreted with
caution and should not be taken as representative of the majority
of Latin American population. This sample did not include US Native Americans, who have also been impacted by COVID-19 [43].
Data were self-reported. Further, we did not collect information
on race in Latin America, which prevents us from learning about
within-Latino ethnoracial differences. Similar to the US, ethnoracial minorities in Latin America might experience a higher burden
of COVID-19 compared to the non-ethnoracial minority population.
Furthermore, there is considerable heterogeneity (sociocultural, resources, COVID-19 pandemic management, among others) across
the Latin American countries included. Future studies should examine potential differences across these countries. Some data, such
as COVID-19 positivity, cognition, or physical health, could have
been collected more reliably via performance, clinical, or laboratory assessments. Measures were forward-and-back translated but
have not all been validated in Spanish, which may impact results’
validity and reliability. Finally, most of our participants were female, which matches the patterning distribution observed in other
clinical studies [44], but does not represent the entire population.
As many countries struggle with the evolving surge and ebb
of the COVID-19 pandemic, research and public policy shift to upstream social determinants of health that increase the communitywide risk for vulnerable populations like older adults and ethnoracial groups. This international study had a number of strengths including, prospectively surveying over 1600 older adults across the
US and in 4 Latin American countries, over 700 participants residing in Argentina, Chile, Mexico, and Peru, employing a battery
of valid, psychosocial measures and a comprehensive pandemic inventory. Discrimination, loneliness, life purpose, and memory concerns deeply inﬂuence an individual’s health and interact with social determinants of health. Ethnoracial groups and older adults are
at a higher risk for health disparities, and COVID-19 exponentially
increases mortality and morbidity risks. Future studies should examine how mediators like income and coping skills modify the
pandemic’s impact. The pandemic likely has a differential impact
across countries; between-country differences should be examined.
The percentage of reported positive COVID-19 cases was low in this
sample, yet, these results highlight salient themes that physicians
and other healthcare workers need to be cognizant of when working with high-risk populations.
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